We are live on ! Find out more
BLFS icon

BioLife Solutions

54 hedge funds and large institutions have $90.5M invested in BioLife Solutions in 2018 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 17 increasing their positions, 13 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 13

0% more funds holding

Funds holding: 5454 (0)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 15

5.47% less ownership

Funds ownership: 46.15%40.68% (-5.5%)

32% less capital invested

Capital invested by funds: $133M → $90.5M (-$42.7M)

Holders
54
Holders Change
Holders Change %
0%
% of All Funds
1.2%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
15
Increased
17
Reduced
13
Closed
15
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
CC
1
Casdin Capital
New York
$29.2M
SCM
2
Sandler Capital Management
New York
$11.6M +$2.2M +184,253 +24%
Vanguard Group
3
Vanguard Group
Pennsylvania
$6.7M +$1.31M +109,284 +24%
Renaissance Technologies
4
Renaissance Technologies
New York
$5.33M +$186K +15,600 +4%
DCM
5
Driehaus Capital Management
Illinois
$5.22M -$838K -70,204 -14%
SSA
6
Schonfeld Strategic Advisors
New York
$4.05M -$380K -31,800 -9%
EIM
7
Essex Investment Management
Massachusetts
$3.71M +$392K +32,788 +12%
CCM
8
Cadence Capital Management
Massachusetts
$2.31M +$677K +56,651 +42%
First Eagle Investment Management
9
First Eagle Investment Management
New York
$2.14M +$2.12M +177,578 New
BlackRock
10
BlackRock
New York
$1.84M -$8.74K -732 -0.5%
GIM
11
Granahan Investment Management
Massachusetts
$1.59M -$30.6K -2,560 -2%
Ameriprise
12
Ameriprise
Minnesota
$1.23M +$1.22M +102,311 New
RIM
13
Ranger Investment Management
Texas
$1.11M +$1.1M +92,063 New
Wells Fargo
14
Wells Fargo
California
$1.07M +$166K +13,893 +18%
DFAM
15
Deep Field Asset Management
California
$1.03M +$1.03M +86,040 New
Geode Capital Management
16
Geode Capital Management
Massachusetts
$1M +$254K +21,267 +34%
GIP
17
Granite Investment Partners
California
$988K
CS
18
Candriam SCA
Luxembourg
$914K
Barclays
19
Barclays
United Kingdom
$877K +$866K +72,500 +18,125%
Susquehanna International Group
20
Susquehanna International Group
Pennsylvania
$830K +$824K +69,035 New
Bank of New York Mellon
21
Bank of New York Mellon
New York
$781K +$206K +17,209 +36%
Two Sigma Investments
22
Two Sigma Investments
New York
$751K -$518K -43,369 -41%
Acadian Asset Management
23
Acadian Asset Management
Massachusetts
$732K -$102K -8,501 -12%
PCM
24
Perkins Capital Management
Minnesota
$611K -$1.06M -88,400 -64%
Northern Trust
25
Northern Trust
Illinois
$598K +$95.6K +8,003 +19%

BLFS Hedge Fund Activity: Q4 2018 in Review

54 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q4 2018, worth a combined $90.5M — down 32% from $133M a quarter earlier.

Fund positioning in BLFS was balanced in Q4 2018: 15 funds opened new positions, 15 closed out, 17 added to existing stakes and 13 trimmed.

The largest buyer was Sandler Capital Management, adding an estimated $2.2M. The largest seller was Venator Capital Management, exiting entirely with an estimated $7.06M sold.

  • 54 institutional investors held BioLife Solutions (BLFS) as of Q4 2018, unchanged from Q3 2018.
  • Funds reported $90.5M of BioLife Solutions stock for Q4 2018, down 32% quarter-over-quarter.
  • 15 funds opened new BioLife Solutions positions in Q4 2018 and 15 closed out, a net change of 0 holders.
  • The largest BioLife Solutions buyer in Q4 2018 was Sandler Capital Management, an estimated $2.2M added.
  • The largest BioLife Solutions seller in Q4 2018 was Venator Capital Management, an estimated $7.06M sold.

Based on aggregated 13F filings for Q4 2018.